# About rxDSIP — An Editorial Digest of the DSIP Literature

> About rxDSIP: an independent editorial project summarizing the peer-reviewed DSIP research literature. Not a clinic, not a vendor — a cited, plain-spoken reading of the science.

A reader of the literature, standing at the edge of the riddle — not a clinic, not a counter.

## What this site is

rxDSIP is an independent editorial project that publishes plain-English summaries of the peer-reviewed research literature on DSIP — the delta sleep-inducing peptide. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The whole reason this site exists is that the DSIP literature is scattered, contradictory, and easy to misread — a striking founding finding wrapped in forty years of nulls and a missing receptor. We gather those studies into one place, read them in order, and try to be exactly as confident as the evidence allows: clear where it is clear, honest where it is thin.

## What the name means

The 'rx' in rxDSIP is editorial framing — a position this publisher occupies relative to the literature, a vantage from which to read it closely — not a claim about services. We are not a pharmacy, we write no prescriptions, and nothing here is a recommendation to use DSIP. We have no doctors, no pharmacists, no clinical team, no physical clinic, and no consultation service. The modifier names a stance toward the research, nothing more.

We also do not invent. Every finding on this site is drawn from a cited study; where the community reports something the studies have not measured, we label it plainly as anecdote. Where the evidence simply does not exist — a human pharmacokinetic profile, a long-term safety record, a known receptor — we say so rather than fill the gap.

## How we read DSIP

Our editorial stance on DSIP is deliberate honesty about uncertainty. We surface the real findings — the delta-wave enhancement, the modest human sleep studies, the animal hormone and longevity work — and we keep their limits in equal view: the non-replications, the parabolic dose-response, the absent receptor, and the frequent reports of no effect at all. DSIP is a fascinating, genuinely unresolved molecule, and we think the most useful thing a digest can do is hold its mystery and its evidence side by side without resolving either prematurely.

---

A nocturnal field guide to DSIP, the delta sleep-inducing peptide — the slow-wave findings drawn out where the studies show them, the missing receptor and the nights nothing happened left openly in the dark, with no clinic at the bedside and nothing here dosed, supplied, or sold.